OverviewSuggest Edit

Ekso Bionics is committed to applying the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable. Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley, received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation. Today Ekso Bionics continues to pioneer the field of exoskeletons, designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human mobility and capability.
TypePublic
Founded2005
HQHamburg, DE
Websiteeksobionics.com
Employee Ratings4.1

Latest Updates

Employees (est.) (Dec 2019)67(-12%)
Revenue (FY, 2019)$13.9 M(+23%)
Share Price (Oct 2020)$4.6 (-2%)
Cybersecurity ratingBMore

Key People/Management at Ekso Bionics

Bill Shaw

Bill Shaw

CCO
Jack Peurach

Jack Peurach

President, Chief Executive Officer and Director
Steven Sherman

Steven Sherman

Executive Chairman
Foon Lim

Foon Lim

President, APAC
Marilyn Hamilton

Marilyn Hamilton

Director
Jack Glenn

Jack Glenn

CFO
Show more

Ekso Bionics Office Locations

Ekso Bionics has offices in Hamburg and Richmond
Hamburg, DE (HQ)
Friesenweg 4
Richmond, US
Richmond, CA, USA
Show all (2)

Ekso Bionics Financials and Metrics

Ekso Bionics Revenue

Ekso Bionics's revenue was reported to be $13.92 m in FY, 2019
USD

Revenue (Q2, 2020)

2.3m

Gross profit (Q2, 2020)

1.3m

Gross profit margin (Q2, 2020), %

55.6%

Net income (Q2, 2020)

(11.8m)

EBIT (Q2, 2020)

(3.1m)

Market capitalization (19-Oct-2020)

38.1m

Closing stock price (19-Oct-2020)

4.6

Cash (30-Jun-2020)

13.3m

EV

28.7m
Ekso Bionics's current market capitalization is $38.1 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.3m8.7m14.2m7.4m11.3m13.9m

Cost of goods sold

3.8m7.5m11.3m5.3m7.0m7.2m

Gross profit

1.6m1.2m2.9m2.1m4.3m6.8m

Gross profit Margin, %

29%14%21%28%38%49%
Quarterly
USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

1.1m1.2m1.6m1.7m2.1m2.9m8.5m1.6m1.6m1.4m1.9m1.6m2.5m3.0m2.6m3.6m3.3m3.3m1.5m2.3m

Cost of goods sold

582.2k1.2m1.1m1.3m1.6m2.4m7.0m1.3m1.2m1.1m1.5m1.1m1.8m2.0m1.5m2.0m1.7m1.6m831.0k1.0m

Gross profit

479.5k45.6k479.8k403.0k502.0k468.0k1.5m203.0k403.0k352.0k396.0k544.0k767.0k967.0k1.1m1.6m1.6m1.8m637.0k1.3m

Gross profit Margin, %

45%4%30%24%24%16%18%13%25%25%21%34%30%33%42%44%48%53%43%56%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

29.2k25.2m19.6m16.8m27.8m7.7m10.9m

Accounts Receivable

1.5m2.1m2.8m3.7m5.2m

Prepaid Expenses

388.0k436.0k1.3m281.0k238.0k

Inventories

622.0k1.1m1.6m3.0m3.4m2.5m
Quarterly
Show all financial metrics

Ekso Bionics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

83/100

SecurityScorecard logo

Ekso Bionics Online and Social Media Presence

Embed Graph

Ekso Bionics News and Updates

Thinking about buying stock in Soligenix Inc, Ekso Bionics, SINTX Technologies, AIM ImmunoTech, or Nio Inc?

NEW YORK, June 26, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNGX, EKSO, SINT, AIM, and NIO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Ekso Bionics shares soar after company gets FDA clearance to use robotic exoskeleton in acquired brain injury

Shares of Ekso Bionics Holdings Inc. soared Thursday, after the company said it has received 501 clearance from the U.S. Food and Drug Administration to market its EksoNR robotic exoskeleton for use in patients with acquired brain injury, or ABI. The device is first to get FDA clearance for use wit…

Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?

NEW YORK, June 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EKSO, AAPL, GNC, MSFT, and APVO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2019 Financial Results; Company Achieves Record Fourth Quarter Revenue

RICHMOND, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2019.

Ekso Bionics introduces EksoNR exoskeleton for neurorehab

Ekso Bionics, the Richmond, Calif.-based developer of medical and industrial exoskeletons, today unveiled EksoNR, the next-generation version of its EksoGT. The EksoNR is designed to help patients who are recovering from stroke or other conditions learn to walk again with a more natural gait. The Ek…

Ekso Bionics Announces Closing of $10 Million Public Offering

RICHMOND, Calif., May 24, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company,” “Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, announced today the closing of its previously announced underwritten public offering…
Show more

Ekso Bionics Blogs

EVO Vest Addresses Challenges of the Industrial Worker

There are many challenges facing the industrial worker, from fatigue to heat exposure to repetitive motion. To address those concerns, we have created EVO, the result of three years of intense testing, research and market feedback. Making improvements to the design, manufacturing, and ergonomics, …

Young Mother Finds Her ‘New Normal’ After Stroke

As a mother of three active boys and working three jobs, it's no secret that Amelia Clark, at 38, is a hard worker. With no time left in her day to be ill, it was an unwelcome surprise when she started to feel sick at her local salon. Developing a sudden headache, she was [...]

Lift Tools All Day with New Passive Exoskeleton

The post Lift Tools All Day with New Passive Exoskeleton appeared first on Ekso Bionics.

Designing for dignity: Ekso Bionics’ robotic exoskeleton gives hope and strength

The post Designing for dignity: Ekso Bionics’ robotic exoskeleton gives hope and strength appeared first on Ekso Bionics.
Show more

Ekso Bionics Frequently Asked Questions

  • When was Ekso Bionics founded?

    Ekso Bionics was founded in 2005.

  • Who are Ekso Bionics key executives?

    Ekso Bionics's key executives are Bill Shaw, Jack Peurach and Steven Sherman.

  • How many employees does Ekso Bionics have?

    Ekso Bionics has 67 employees.

  • What is Ekso Bionics revenue?

    Latest Ekso Bionics annual revenue is $13.9 m.

  • What is Ekso Bionics revenue per employee?

    Latest Ekso Bionics revenue per employee is $207.7 k.

  • Who are Ekso Bionics competitors?

    Competitors of Ekso Bionics include ReWalk Robotics, Fesia Technology and Movendo Technology.

  • Where is Ekso Bionics headquarters?

    Ekso Bionics headquarters is located at Friesenweg 4, Hamburg.

  • Where are Ekso Bionics offices?

    Ekso Bionics has offices in Hamburg and Richmond.

  • How many offices does Ekso Bionics have?

    Ekso Bionics has 2 offices.